Progyny, Inc. Payments of Stock Issuance Costs
Progyny, Inc. (PGNY) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-01
- Progyny, Inc. payments of stock issuance costs for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Progyny, Inc. payments of stock issuance costs for the quarter ending 2020-09-30 was $101.00K.
- Progyny, Inc. payments of stock issuance costs for the quarter ending 2020-06-30 was $0.00.
- Progyny, Inc. payments of stock issuance costs for the quarter ending 2020-03-31 was $791.00K.
- Progyny, Inc. payments of stock issuance costs for fiscal 2022 was $0.00.
- Progyny, Inc. payments of stock issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Progyny, Inc. payments of stock issuance costs for fiscal 2020 was $892.00K, a 68.54% decline from fiscal 2019.
- Progyny, Inc. payments of stock issuance costs for fiscal 2019 was $2.83M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $101.00K derived: sum of 2 quarters · filed 2023-03-01 | $101.00K derived: sum of 3 quarters · filed 2023-03-01 | $892.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $101.00K derived: sum of 2 quarters · filed 2021-11-08 | $892.00K 10-Q · filed 2021-11-08 | $3.21M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $791.00K 10-Q · filed 2021-08-06 | $3.11M derived: sum of 3 quarters · filed 2022-03-01 | $2.88M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $791.00K 10-Q · filed 2021-05-07 | $3.11M derived: sum of 2 quarters · filed 2022-03-01 | $2.88M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.09M derived: sum of 2 quarters · filed 2022-03-01 | $2.83M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $512.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $748.00K 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |